A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...
Medpage Today on MSN14d
Dupilumab Improves Quality of Life for COPD PatientsPatients with chronic obstructive pulmonary disease (COPD) and type 2 inflammation had greater improvements in quality of ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...
Boehringer Ingelheim has announced an increase in sales ... approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared ...
Hosted on MSN7mon
Experts say Medicaid rebate change is behind inhaler price cutsA recent tweak to a Medicaid formula could be behind the shakeup to inhaler products, a series of changes which have both benefited and harmed patients with asthma and chronic obstructive pulmonary ...
Bronchiectasis is a clinical condition defined as a chronic, abnormal dilation of the bronchi accompanied by classical ...
The global Chronic Obstructive Pulmonary Disease (COPD) treatment market is projected to experience steady growth over the ...
Global Pleural Diseases Therapeutics Market to Reach USD 9.4 Billion by 2033, Growing at a 6.5% CAGR
Global Pleural Diseases Therapeutics MarketThe global market for pleural diseases therapeutics is projected to experience ...
The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...
The global airway disease treatment market is projected to experience significant growth over the next decade, with revenue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback